21.08.2019 14:59:16
|
Perrigo Settles Patent Litigation On Generic Version Of Nascobal Nasal Spray
(RTTNews) - Perrigo Company plc (PRGO) said that it has settled its Hatch-Waxman litigation relating to Nascobal Nasal Spray brought by Endo Pharmaceuticals Inc. It did not disclose terms of the settlement.
According to IQVIA, annual market sales for the 12-months ending June 2019 were $90 million.
Perrigo Executive Vice President and President Rx Pharmaceuticals Sharon Kochan said, ".... Our R&D, operations and legal teams continue to work diligently and relentlessly to introduce new generic products that provide savings to patients and healthcare systems."

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Perrigo Company PLCmehr Nachrichten
Analysen zu Perrigo Company PLCmehr Analysen
Aktien in diesem Artikel
Perrigo Company PLC | 23,83 | 1,06% |
|